Aquestive Therapeutics is a pharmaceutical company. Co. is improving medicines to solve patients' problems with care and provide transformative products to improve their lives. Co. is developing pharmaceutical products that deliver molecules through alternative administrations to invasive and inconvenient standard of care therapies. Co. also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, like PharmFilm®. Co. is developing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. Co. has also developed a product pipeline focused on treating diseases of the central nervous system (CNS).
|
Free AQST Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.87 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Analysts' Target Price: AQST Stock Forecast Based on Zacks ABR data; powered by Xignite |